IP Library Granted Patent US 8,544,473
Granted Patent B2
US 8,544,473 · App. 12/204,638 · Granted Oct 1, 2013

Methods for treating eye conditions with low-level light therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,544,473
App. No.
12/204,638
Granted
Oct 1, 2013
Kind
B2
Abstract

Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal and other manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.

Claims (11)

1. A method for imparting a tissue treatment to an eye in need of one or more of a physiological and a vision correction, comprising:

generating low-level treatment radiation;

penetrating conjunctiva of the eye with the low-level treatment radiation; and

projecting the low-level treatment radiation onto one or more of a sclera and a ciliary muscle of the eye, so that the low-level treatment radiation imparts a therapeutic treatment affect to but does not ablate tissue of the one or more of a sclera and a ciliary muscle, the low-level treatment radiation projected onto one or more of the sclera and the ciliary muscle being at a greater concentration than a concentration of low-level, treatment energy penetrating the conjunctiva.

2. The method as set forth in claim 1 , wherein a wavelength of the treatment energy is of a type that is more highly absorbed by a type of tissue corresponding to that of (i) the sclera or the ciliary muscle than by a type of tissue corresponding to that of (ii) the conjunctiva.

3. The method as set forth in claim 1 , wherein the therapeutic treatment affect is an enhancement of one or more of an accommodation of the eye and an elasticity of tissue of the one or more of a sclera and a ciliary muscle.

4. The method as set forth in claim 1 , and further comprising focusing a dose of electromagnetic radiation onto one or more of the sclera and the ciliary muscle of the eye, to thereby impart ablative forces onto the one or more of a sclera and a ciliary muscle.

5. The method as set forth in claim 1 , wherein the projecting comprises projecting, low-level treatment radiation onto one or more of a zonule and a lens of the eye, so that the low-level treatment radiation imparts a therapeutic treatment affect to but does not ablate tissue of the one or more of a zonule and a lens of the eye.

6. The method as set forth in claim 5 , and further comprising focusing a dose of electromagnetic radiation onto one or more of a zonule and a lens of the eye, to thereby impart ablative forces onto the one or more of a zonule and a lens of the eye.

7. The method as set forth in claim 1 , wherein the therapeutic doses of enemy comprise sonic energy.

8. The method as set forth in claim 1 , wherein the therapeutic doses of energy comprise pulsed therapeutic doses of one or more of electrical potential or current, sonic energy, and magnetism.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2024
From: BIOLASE, INC.; BL ACQUISITION CORP.; BL ACQUISITION II, INC.
To: BIOLASE MG LLC
Reel/Frame 069715/0613 →
SECURITY INTEREST Recorded Oct 30, 2019
From: BIOLASE, INC.
To: PACIFIC MERCANTILE BANK
Reel/Frame 050879/0223 →
SECURITY INTEREST Recorded Nov 16, 2018
From: BIOLASE, INC.
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 047588/0192 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2018
From: WESTERN ALLIANCE BANK
To: BIOLASE, INC.
Reel/Frame 048101/0027 →
SECURITY INTEREST Recorded Mar 7, 2018
From: BIOLASE, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 045514/0540 →
CHANGE OF NAME Recorded Nov 20, 2012
From: BIOLASE TECHNOLOGY, INC.
To: BIOLASE, INC.
Reel/Frame 029328/0096 →
RELEASE OF SECURITY INTEREST Recorded May 9, 2012
From: HENRY SCHEIN, INC.
To: BIOLASE TECHNOLOGY, INC.; BL ACQUISTION CORP.; BL ACQUISITION II INC.
Reel/Frame 028184/0218 →
SECURITY AGREEMENT PAYOFF Recorded May 16, 2011
From: MIDCAP FINANCIAL, LLC, AGENT AND AS LENDER
To: BIOLASE TECHNOLOGY, INC.
Reel/Frame 026285/0666 →
SECURITY AGREEMENT Recorded Sep 30, 2010
From: BIOLASE TECHNOLOGY, INC.; BL ACQUISITION CORP.; BL ACQUISITION II INC.
To: HENRY SCHEIN, INC.
Reel/Frame 025066/0488 →
SECURITY AGREEMENT Recorded Aug 28, 2010
From: BIOLASE TECHNOLOGY, INC.
To: MIDCAP FINANCIAL, LLC, AS AGENT AND AS A LENDER
Reel/Frame 024900/0550 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2008
From: JONES, JEFFREY W.; RIZOIU, IOANA M.
To: BIOLASE TECHNOLOGY, INC.
Reel/Frame 021839/0463 →